SCHEMBL4070923

SCHEMBL4070923

CCOCCOCCS(=O)(=O)CC#N

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
NLRP3 Q96P20 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4082522 0.96 NLRP3 (0.32) ALDH1A1TSHRNLRP3
SCHEMBL4070183 0.85 CA2 (0.42) NLRP3
SCHEMBL15529598 0.76 ALDH1A1 (0.41) ALDH1A1TSHR
SCHEMBL2487543 0.75 NLRP3 (0.34) NLRP3
SCHEMBL1161080 0.74 ALDH1A1 (0.39) ALDH1A1TSHR
SCHEMBL4006475 0.72
Acetonitrile SCHEMBL28114814 0.71 ALDH1A1 (0.45) ALDH1A1TSHR
SCHEMBL2489444 0.71 NLRP3 (0.31) NLRP3
Propane SCHEMBL8719519 0.70 NLRP3 (0.37) ALDH1A1TSHRNLRP3
SCHEMBL12410359 0.70 ALDH1A1 (0.36) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1625112-B1 NOVEL COMPOUNDS FOR TREATMENT OF OBESITY HIGH POINT PHARMACEUTICALS LLC (US) 2009-07-22 EP disclosed
EP-1625112-A1 NOVEL COMPOUNDS FOR TREATMENT OF OBESITY NOVO NORDISK A/S (DK) 2006-02-15 EP disclosed
WO-2004101505-A1 NOVEL COMPOUNDS FOR TREATMENT OF OBESITY NOVO NORDISK A/S (DK) 2004-11-25 WO disclosed